US HR309 | 2023-2024 | 118th Congress

Status

Spectrum: Partisan Bill (Democrat 49-0)
Status: Introduced on April 19 2023 - 25% progression
Action: 2023-04-19 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.

Sponsors


History

DateChamberAction
2023-04-19HouseReferred to the House Committee on Energy and Commerce.
2023-04-19HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback